Status:
UNKNOWN
Smartphone-based Brainwave Entrainment (BWE) Technology in Chronic Pain
Lead Sponsor:
Helen Locke
Collaborating Sponsors:
University of Leeds
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Is brainwave entrainment a feasible tool for managing long-term pain in a patient population in the home-setting? Long-term pain affects 4 in 10 people in the UK and can impact on all aspects of life....
Detailed Description
Primary Question/Objective: The principal research objectives are two-fold: * Firstly, to understand the dose-response of alpha BWE. * Secondly, to test the feasibility of using alpha BWE technology...
Eligibility Criteria
Inclusion
- adults over the age of 18 years (there is no upper age limit as we would want the intervention to be as inclusive as possible)
- clinically significant non-cancer-related chronic pain (for which they have sought medical input) for more than three months' duration
- willing and able to consent to taking part.
Exclusion
- any history or first-degree relative history of epilepsy or convulsions/seizures
- discomfort with flashing lights
- history of recurrent headaches or migraines
- participants who have difficulty understanding verbal or written English, or who have cognitive or mental health problems that would prevent them being able to provide written informed consent
- planned intervention (surgery, new medications or treatments) during the study period.
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04493775
Start Date
October 1 2021
End Date
October 1 2024
Last Update
July 6 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Manchester
Manchester, Lancashire, United Kingdom, M13 9PL
2
University of Leeds
Leeds, West Yorkshire, United Kingdom, LS1 3EX